Lynda Chin, MD
Chief Executive Officer
An elected member of the National Academy of Medicine, Dr. Chin is a renowned cancer genomic scientist and a leader in the application of analytical technologies, AI/ML, and big data in medicine. Her groundbreaking work synthesizing terabyte-scale datasets in genomics and oncology research has opened new frontiers in digital medicine.
As founding chair of the Department of Genomic Medicine at the University of Texas MD Anderson Cancer Center, Dr. Chin launched projects to transform workflows for patient-oriented research harness high-velocity clinical and research data, and democratize cancer care expertise across a network of global partner care centers. As Chief Innovation Officer of the University of Texas System, she forged initiatives to create infrastructure for more equitable access to care for underserved populations. In her work at The Cancer Genome Atlas (TCGA), she was Principal Investigator driving development of the Firehose data pipeline, served on the Scientific Steering Committee of the International Cancer Genome Consortium (ICGC), and is actively involved in conceptualizing the next phase of ICGC, ICGC-ARGO (Accelerating Research on Genomic Oncology).
Dr. Chin earned a B.A. degree from Brown University and a M.D. degree from Albert Einstein College of Medicine. She conducted her clinical and scientific training at Columbia Presbyterian Medical Center and Montefiore Medical Center in NY and went on to a productive academic research career at Dana-Farber Cancer Institute, where she was a professor at Harvard Medical School and a senior associate member at the Broad Institute of MIT and Harvard.